-

Ventas Announces Tax Treatment Of 2022 Distributions

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (the “Company”) announced today the tax treatment of its 2022 distributions on the Company’s common stock.

For income tax purposes, total taxable dividend income for 2022 was $1.80 per share. This includes the Company’s fourth quarter 2021 dividend of $0.45 per share, which was declared on December 7, 2021 and was paid on January 19, 2022. It excludes the Company’s fourth quarter 2022 dividend, which was declared on December 7, 2022, will be paid on January 19, 2023 and will be taxable to stockholders as part of their 2023 dividend income.

The following table summarizes the nature of these cash distributions and provides the appropriate Form 1099-DIV box number:

2022 DISTRIBUTIONS ON VENTAS COMMON STOCK

Date Paid

Taxable

Distribution

Box 1a
Ordinary
Dividend

Box 1b
Qualified
Dividend (Included in

Box 1a)

 

 

 

Box 5

199A

Dividend

(Included in Box 1a)

 

 

 

 

 

Box 2a

Capital

Gain Distr.

 

 

Box 2b

Unrecap. Section

1250 Gain

(Included in

Box 2a)

 

 

Box 2f

Section 897

Capital Gain

(included in Box 2a)

Jan. 19, 2022

$0.450000

$0.450000

$0.012265

$0.437735

$0.000000

$0.000000

$0.000000

Apr. 14, 2022

$0.450000

$0.450000

$0.012265

$0.437735

$0.000000

$0.000000

$0.000000

July 14, 2022

$0.450000

$0.450000

$0.012265

$0.437735

$0.000000

$0.000000

$0.000000

Oct. 14, 2022

$0.450000

$0.450000

$0.012265

$0.437735

$0.000000

$0.000000

$0.000000

Total Taxable in 2022

$1.800000

$1.800000

$0.049060

$1.750940

$0.000000

$0.000000

$0.000000

The 2022 Non-Qualified Ordinary Dividends are also reported on Form 1099-DIV, Box 5, Section 199A Dividends. Treasury Regulation §1.199A-3(c)(2)(ii) requires that shareholders hold their REIT shares for at least 45 days in order for the dividends to be treated as Section 199A Dividends. Pursuant to Treasury Regulation §1.1061-6(c), the Company reports that for purposes of Section 1061 of the Internal Revenue Code, the One Year Amounts Disclosure and the Three Year Amounts Disclosure are $0.00 with respect to direct and indirect holders of “applicable partnership interests.” Stockholders are encouraged to consult their own tax advisors regarding the tax consequences of these distributions.

About Ventas

Ventas Inc., an S&P 500 company, operates at the intersection of two large and dynamic industries – healthcare and real estate. Fueled by powerful demographic demand from growth in the aging population, Ventas owns a diversified portfolio of over 1,200 properties in the United States, Canada, and the United Kingdom. Ventas uses the power of its capital to unlock the value of senior living communities; life science, research & innovation properties; medical office & outpatient facilities, hospitals and other healthcare real estate. A globally-recognized real estate investment trust, Ventas follows a successful long-term strategy, proven over more than 20 years, built on diversification of property types, capital sources and industry leading partners, financial strength and flexibility, consistent and reliable growth and industry leading ESG achievements, managed by a collaborative and experienced team dedicated to its stakeholders.

Contacts

BJ Grant
(877) 4-VENTAS

Ventas Inc.

NYSE:VTR

Release Versions

Contacts

BJ Grant
(877) 4-VENTAS

More News From Ventas Inc.

Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its second quarter 2026 earnings release after the close of trading on the New York Stock Exchange on Wednesday, July 29, 2026. A conference call to discuss those earnings will be held on Thursday, July 30, 2026 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can b...

Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that the Company has named Andrew L. Wattula Executive Vice President, Outpatient Medical & Research and CEO of Lillibridge Healthcare Services, a wholly-owned property management and leasing subsidiary of Ventas, effective August 2026. He will oversee the Company’s differentiated outpatient medical and research business, which is a leading owner and manager of properties operating at the intersec...

Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) today announced that Chairman and Chief Executive Officer Debra A. Cafaro will receive the Cyrus McCormick Making History Award for Historic Corporate Achievement at the Chicago History Museum’s 32nd Annual Making History Awards this evening. The Cyrus McCormick Making History Award for Historic Corporate Achievement recognizes business leaders and organizations whose work has made enduring contributions to Chicago’s economic and civic life. Un...
Back to Newsroom